Nirvana Life Sciences Inc. filed its Annual on Aug 29, 2022 for the period ending Apr 30, 2022. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -62.50% | -62.50% | -25.00% |
1st Jan change | Capi. | |
---|---|---|
-25.00% | 525K | |
+48.62% | 56.87B | |
+37.15% | 39.72B | |
-5.67% | 39.27B | |
-6.90% | 28.73B | |
+13.02% | 26.21B | |
-16.02% | 19.79B | |
+31.47% | 12.28B | |
+28.26% | 12.23B | |
+0.45% | 12.12B |
- Stock Market
- Equities
- NIRV Stock
- News Nirvana Life Sciences Inc.
- Nirvana Life Sciences Inc. Auditor Raises 'Going Concern' Doubt